Use of anti-infective drugs in rheumatology

Jacob N. Ablin*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The clinical field of rheumatology utilizes numerous medications which are either structurally derived from antibiotic compounds or are actually originally track - record proven anti - infective agents adapted for use in this field. Though in many cases, exemplified by rheumatoid arthritis, a presumed infectious etiology brought about the introduction of these drugs into rheumatology, subsequent research has often failed to demonstrate an infectious agent; nevertheless such originally anti - infectious agents as hydroxychloroquine and sulfasalazine have gained a place in the rheumatologic armamentarium. This sequence of events implies that in many cases anti - infective agents posses anti - inflammatory or immuno - modulatory qualities not directly linked to their potential capacity to kill foreign pathogens. More recently agents such as cyclosporine and tacrolimus, both of antibiotic structure, have been developed specifically for their immuno - modulatory effects. This review covers the main events in the development of anti - infective agents for rheumatology and attempts to clarify the often enigmatic relationship between these two seemingly unrelated fields.

Original languageEnglish
Pages (from-to)55-61
Number of pages7
JournalAnti-Infective Agents in Medicinal Chemistry
Issue number1
StatePublished - Jan 2006
Externally publishedYes


  • Cyclosporine
  • Hydroxychloroquine
  • Minocycline
  • Rheumatoid arthritis
  • Rheumatology
  • Sulfasalazine
  • Systemic lupus erythematosus
  • Tacrolimus
  • Tetracyclines


Dive into the research topics of 'Use of anti-infective drugs in rheumatology'. Together they form a unique fingerprint.

Cite this